Cargando…
The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol
Understanding the pathophysiology of Alzheimer's disease (AD) is essential to improve the efficacy of treatments and, consequently, patients' lives. Unfortunately, traditional therapeutic strategies have not been effective. There is therefore an urgent need to discover or develop alternati...
Autores principales: | Oliveira, Bruna Stefane Alves de, Milanezi, Debora Sandrini, Gonzaga, Priscila do Val, Detoni, Fernanda Rabello, Soriano, Renato Nery |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761731/ https://www.ncbi.nlm.nih.gov/pubmed/36544841 http://dx.doi.org/10.1016/j.heliyon.2022.e12172 |
Ejemplares similares
-
Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
por: Viana, Milena de Barros, et al.
Publicado: (2022) -
Cannabidiol for neurodegenerative disorders: A comprehensive review
por: Bhunia, Sukanya, et al.
Publicado: (2022) -
Cannabidiol: potential in treatment of neurological diseases, flax as a possible natural source of cannabidiol
por: Storozhuk, Maksim V.
Publicado: (2023) -
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020) -
hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible
por: Rivetti di Val Cervo, Pia, et al.
Publicado: (2021)